Skip to main content
RAPP logo

RAPP · Rapport Therapeutics, Inc.

Track RAPP — free
$47.42 +0.06 (+0.13%) At close · Aug 14
Market Cap
$2.28B
Shares
47.98M

Notices of intent to sell restricted or control shares, filed with the SEC on Form 144 by insiders and affiliates. A Form 144 signals a planned sale — it does not confirm the shares were actually sold.

Filed Seller Shares
2026-06-30 CHERYL GAULT 10,000
2026-05-27 Third Rock Ventures V, L.P. 18,572
2026-05-11 Third Rock Ventures V, L.P. 133,618
2026-05-08 Third Rock Ventures V, L.P. 5,018
2026-05-07 Third Rock Ventures V, L.P. 271,495
2026-04-17 KRISHNASWAMY YELESWARAM 20,225
2026-04-17 Third Rock Ventures V, L.P. 426,005
2026-04-13 KRISHNASWAMY YELESWARAM 19,365
2026-04-10 KRISHNASWAMY YELESWARAM 500
2026-04-08 KRISHNASWAMY YELESWARAM 360
2026-03-30 CHERYL GAULT 10,000
2026-03-25 KRISHNASWAMY YELESWARAM 10,115
2026-03-05 Gault Cheryl 2,014
2026-01-15 DAVID BREDT 17,000
2026-01-02 Krishnaswamy Yeleswaram 2,840
2026-01-02 DAVID BREDT 6,567
2025-12-17 ABRAHAM CEESAY 17,499
2025-12-17 THE DOROTHY CEESAY IRREVOCABLE TRUST 15,249
2025-10-15 DAVID BREDT 25,500
2025-09-17 ABRAHAM CEESAY 52,501
2025-09-17 THE DOROTHY CEESAY IRREV TRUST U/ADTD 03/27/2024 45,751
2025-09-08 CHERYL GAULT 10,000
2025-06-16 DAVID BREDT 34,000
2025-03-14 DAVID BREDT 25,500
Showing 1–24 of 24 filings
Key facts CIK 2012593 CUSIP 75383L102 13F (30d) 156 filings 153 filers Visit website Investor relations